Geode Capital Management
SRPT icon

Geode Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.1M Buy
1,875,997
+55,076
+3% +$942K ﹤0.01% 1688
2025
Q1
$116M Buy
1,820,921
+114,568
+7% +$7.31M 0.01% 893
2024
Q4
$208M Buy
1,706,353
+9,999
+0.6% +$1.22M 0.02% 629
2024
Q3
$212M Buy
1,696,354
+44,306
+3% +$5.53M 0.02% 615
2024
Q2
$261M Buy
1,652,048
+131,678
+9% +$20.8M 0.02% 515
2024
Q1
$197M Buy
1,520,370
+50,833
+3% +$6.58M 0.02% 598
2023
Q4
$142M Buy
1,469,537
+60,762
+4% +$5.86M 0.01% 679
2023
Q3
$171M Buy
1,408,775
+20,692
+1% +$2.51M 0.02% 570
2023
Q2
$159M Buy
1,388,083
+126,112
+10% +$14.4M 0.02% 584
2023
Q1
$174M Buy
1,261,971
+43,239
+4% +$5.96M 0.02% 548
2022
Q4
$158M Buy
1,218,732
+64,434
+6% +$8.35M 0.02% 552
2022
Q3
$128M Buy
1,154,298
+14,915
+1% +$1.65M 0.02% 603
2022
Q2
$85.4M Sell
1,139,383
-9,287
-0.8% -$696K 0.01% 766
2022
Q1
$89.7M Buy
1,148,670
+16,614
+1% +$1.3M 0.01% 844
2021
Q4
$102M Buy
1,132,056
+147,103
+15% +$13.2M 0.01% 815
2021
Q3
$91.1M Buy
984,953
+665
+0.1% +$61.5K 0.01% 856
2021
Q2
$76.5M Buy
984,288
+14,525
+1% +$1.13M 0.01% 965
2021
Q1
$72.2M Buy
969,763
+30,880
+3% +$2.3M 0.01% 951
2020
Q4
$160M Buy
938,883
+52,302
+6% +$8.91M 0.03% 530
2020
Q3
$124M Sell
886,581
-6,545
-0.7% -$918K 0.02% 535
2020
Q2
$143M Buy
893,126
+42,320
+5% +$6.78M 0.03% 464
2020
Q1
$83.2M Buy
850,806
+63,996
+8% +$6.25M 0.02% 559
2019
Q4
$101M Buy
786,810
+28,680
+4% +$3.7M 0.02% 597
2019
Q3
$57.1M Buy
758,130
+15,879
+2% +$1.2M 0.01% 816
2019
Q2
$113M Buy
742,251
+49,567
+7% +$7.53M 0.03% 530
2019
Q1
$82.6M Buy
692,684
+33,931
+5% +$4.04M 0.02% 612
2018
Q4
$71.9M Buy
658,753
+67,601
+11% +$7.38M 0.02% 589
2018
Q3
$95.5M Buy
591,152
+13,587
+2% +$2.19M 0.03% 544
2018
Q2
$76.3M Sell
577,565
-1,827
-0.3% -$241K 0.02% 586
2018
Q1
$42.9M Buy
579,392
+19,936
+4% +$1.48M 0.01% 808
2017
Q4
$31.1M Buy
559,456
+13,631
+2% +$758K 0.01% 959
2017
Q3
$24.8M Buy
545,825
+99,556
+22% +$4.52M 0.01% 1076
2017
Q2
$15M Buy
446,269
+25,222
+6% +$850K 0.01% 1404
2017
Q1
$12.5M Buy
421,047
+29,603
+8% +$876K 0.01% 1475
2016
Q4
$10.7M Buy
391,444
+41,926
+12% +$1.15M 0.01% 1516
2016
Q3
$21.5M Buy
349,518
+55,080
+19% +$3.38M 0.01% 953
2016
Q2
$5.61M Buy
294,438
+12,146
+4% +$232K ﹤0.01% 1832
2016
Q1
$5.51K Sell
282,292
-2,489
-0.9% -$49 ﹤0.01% 1806
2015
Q4
$11M Buy
284,781
+34,677
+14% +$1.34M 0.01% 1316
2015
Q3
$8.03M Buy
250,104
+6,531
+3% +$210K ﹤0.01% 1492
2015
Q2
$7.41M Buy
243,573
+19,384
+9% +$590K ﹤0.01% 1630
2015
Q1
$2.98M Buy
224,189
+6,614
+3% +$87.8K ﹤0.01% 2180
2014
Q4
$3.15M Buy
217,575
+1,631
+0.8% +$23.6K ﹤0.01% 2119
2014
Q3
$4.56M Sell
215,944
-1,853
-0.9% -$39.1K ﹤0.01% 1822
2014
Q2
$6.49M Buy
217,797
+24,959
+13% +$744K ﹤0.01% 1623
2014
Q1
$4.63M Buy
192,838
+21,025
+12% +$505K ﹤0.01% 1823
2013
Q4
$3.5M Buy
171,813
+27,933
+19% +$569K ﹤0.01% 1954
2013
Q3
$6.8M Buy
143,880
+18,442
+15% +$871K 0.01% 1345
2013
Q2
$4.77M Buy
+125,438
New +$4.77M ﹤0.01% 1445